Tag: genomics
-

Synthetic DNA Company Raises $24M in Early Funds
A company with a technology it says is simpler and more like natural processes to produce synthetic DNA is raising $24 million in its first venture round.
-

Gene Therapy Company Exploring DNA Circuit Technology
Spark Therapeutics, a developer of gene therapies, is gaining access to a technology that programs DNA sequences like integrated electronic circuits.
-

Vaccine Stops Lyme Bacteria in Preclinical Test
A study with lab mice shows an experimental vaccine with engineered bacteria produces antibodies and protects against microbes causing Lyme disease.
-

NIH Trial Testing mRNA Vaccine Allergic Effects
A clinical trial is underway testing for allergic reactions to Covid-19 vaccines using messenger RNA for invoking an immune response.
-

Microsoft, Biotech Partner on Metastatic Cancer
A biotechnology start-up is collaborating with Microsoft Corp. on computational tools to find and predict factors that cause cancers to spread.
-

Graphene Crispr Chip Detects Small Genetic Differences
An academic-industry team designed a computer chip with graphene circuits using the gene-editing technique Crispr to detect fine genetic differences in samples.
-

Trial to Test Direct Crispr Blood Stem Cell Edits
A clinical trial is set to begin that tests a direct form of gene editing with Crispr to correct inherited malfunctioning genes causing sickle cell disease.
-

Test Vaccine Protects Against Wide Coronavirus Range
Researchers at two Virginia universities developed an experimental vaccine that in tests with pigs protects against SARS-CoV-2 and other coronaviruses.
-

Venture Fund to Support Seed-Stage Biotechs
A venture capital company raised $50 million to invest in new businesses developing innovative products and services at the junction of biology and engineering.
-

Precision Cancer Immunotherapy Biotech Underway
A new company is beginning work on a safer form of cancer immunotherapy that avoids toxic off-target effects, and raising $55 million in venture funds.